A. Prechtl
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Breast Cancer Treatment Studies, Protease and Inhibitor Mechanisms, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies
Most-Cited Works
- → Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1(2001)438 cited
- → Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies(2009)237 cited
- Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.(1994)
- → Tumor-Biological Factors Upa and PAI-1 as Stratification Criteria of a Multicenter Adjuvant Chemotherapy Trial in Node-Negative Breast Cancer(2000)27 cited
- → Pooled Analysis of uPA and PAI-1 for Prognosis in Primary Breast Cancer Patients(2000)16 cited
- → Effects of Parenteral Application of Fish Oil versus Soy Oil Emulsions on Bacterial Clearance Functions(1999)16 cited
- → Invasionsfaktoren uPA/PAI‐1 im Tumorgewebe bei Patientinnen mit primärem Mammakarzinom: Von Forschungsergebnissen zur klinischen Anwendung am Beispiel der NNBC 3-Europe-Studie(2007)4 cited
- [Blood transfusion in surgical gynecology. Strategies for preventing homologous blood transfusion].(1994)
- → Level-I evidence for prognostic impact of UPA and PAI-1 in node-negative breast cancer patients: Ready for use in clinical routine(2003)1 cited
- → Effects of chemotherapy on olfactory function in breast cancer patients(2008)1 cited